Human FGF-9 Recombinant Protein, PeproTech and 1 more item

The University of Virginia awarded contract A207_PO-0476745 to Life Technologies Corporation on September 3, 2026, for a cumulative value of $1,064.07. The contract involves the procurement of specialized laboratory reagents and equipment, with delivery to Josh Donovan at the University of Virginia. The primary line items include one unit of Human Fibroblast Growth Factor-9 (FGF-9) Recombinant Protein manufactured by PeproTech, valued at $876.12, and three units of MicroAmp Fast Optical 96-Well Reaction Plates (0.1 milliliter capacity) valued at $62.65 per unit, totaling $187.95.

This procurement supports research and development activities within Virginia's higher education sector. Life Technologies Corporation, serving as the prime contractor, supplied critical molecular biology reagents and real-time polymerase chain reaction (PCR) consumables necessary for advanced laboratory applications. The contract represents a routine purchase order transaction typical of academic research institutions requiring specialized scientific materials and equipment for ongoing experimental work.